Johnny Högberg new CEO of Flemingsberg Science

On 1st November, Johnny Högberg will take over as Chief Executive Officer of the Flemingsberg Science Foundation.

The Foundation’s task is to develop southern Stockholm where clinical care and research are already strongly established with world-leading Karolinska University Hospital, the Karolinska Institute, the Royal Institute of Technology (KTH), Södertörn University and several other academies. Flemingsberg Science will contribute to making the Stockholm region one of the five leading Life Science regions in the world.

Johnny Högberg comes from Skellefteå Science City, where he was CEO, and replaces Björn Varnestig, who is giving up his post as CEO in connection with his 65th birthday.

“I am really looking forward to taking on the role of CEO of Flemingsberg Science. The Stockholm region is a strong area of growth in Europe with high ambitions for Life Science in particular. The fact that the region has the stated goal of attracting the EU’s new Health Emergency Preparedness and Response Authority (HERA) is one of several examples of how these ambitions are expressed in practice,” says Johnny Högberg, incoming CEO of Flemingsberg Science.

The foundation’s Chair, Financial Region Councillor Irene Svenonius (M), is pleased with the recruitment of the new CEO.

“We want to improve conditions for growth and development in Flemingsberg and the surrounding area. This will take place in a broad collaboration between the academies, municipalities and the regional authority, with both healthcare and expanded public transport. To achieve our high goals of attracting new companies, EU authorities, headquarters, investments and research, we need people with Johnny’s experience and knowledge,” says Irene Svenonius.

Limitless Potential: Winner of the Flemingsberg Science Award 2025

Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.

It’s official – Alfa Laval has opened its new premises in Flemingsberg!

The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.

50 years of life-changing therapies

On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.